NCT02186873 – A Study of Golimumab in Participants With Active Ankylosing Spondylitis Posted on August 5, 2023 by tsuperadmin -
NCT02846545 – SIMPONI® to Arrest β-cell Loss in Type 1 Diabetes Posted on August 5, 2023 by tsuperadmin -
NCT01453725 – A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Also Known as MK-8259-006-02) Posted on October 23, 2018 by tsuperadmin -
NCT00207740 – A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma Posted on August 6, 2018 by tsuperadmin -
NCT01962974 – A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®) Posted on August 6, 2018 by tsuperadmin -
NCT01988961 – A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis Posted on August 6, 2018 by tsuperadmin -
NCT01863771 – A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis Posted on August 6, 2018 by tsuperadmin -
NCT01004432 – Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Posted on August 6, 2018 by tsuperadmin -
NCT02181673 – A Study of Golimumab in Participants With Active Psoriatic Arthritis Posted on August 6, 2018 by tsuperadmin -
NCT01230827 – A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS) Posted on August 6, 2018 by tsuperadmin -
The YODA Project